Cargando…
Reply: Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine
Autores principales: | Aurora, Sheena, Diener, Hans-Christoph, Dodick, David |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072506/ https://www.ncbi.nlm.nih.gov/pubmed/21461938 http://dx.doi.org/10.1007/s10194-011-0334-4 |
Ejemplares similares
-
Treatment of chronic migraine with Botox (onabotulinumtoxinA): Development, insights, and impact
por: Turkel, Catherine C., et al.
Publicado: (2023) -
Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine
por: Russell, Michael Bjørn
Publicado: (2011) -
Per cent of patients with chronic migraine who responded per onabotulinumtoxinA treatment cycle: PREEMPT
por: Silberstein, Stephen D, et al.
Publicado: (2015) -
Pooled analysis of the safety and tolerability of onabotulinumtoxinA in the treatment of chronic migraine
por: Diener, H-C, et al.
Publicado: (2014) -
OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program
por: Aurora, SK, et al.
Publicado: (2014)